跳轉至內容
Merck
全部照片(1)

重要文件

42000201

Sigma-Aldrich

PRONOVA® UP LVM

low viscosity sodium alginate, viscosity 20-200 mPa.s, 1 %(20 °C)(low), mannuronate monomer units ≥50 %

同義詞:

UP LVM TM=["PRONOVA"]

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352201
NACRES:
NA.25
暫時無法取得訂價和供貨情況

品質等級

形狀

powder

分子量

Mw 75-200 kDa (approximate)

成份

mannuronate monomer units, ≥50%
G/M ratio, ≤1

雜質

≤100 CFU/g Total viable count
≤100 EU/g Endotoxins

pH值

5.5-8.5 (20 °C, 1% in water)

黏度

20-200 mPa.s, 1 %(20 °C) (
low)

一般說明

PRONOVA UP LVM is a low viscosity (20-200 mPas) sodium alginate where minimum 50% of the monomer units are mannuronate.

應用

Examples of Pronova Alginates applications include: encapsulation of living cells and therapeutic proteins for cell therapy medications, cryoprotectant, bone putty binder for tissue engineering, 3D bioprinting, foams and cell tissue scaffolds, hydrogels, advanced drug delivery and implants, wound management, and medical devices.

法律資訊

Product of Dupont Nutrition USA, Inc.
PRONOVA is a registered trademark of International N&H USA, Inc.

免責聲明

NOT FOR USE IN HUMANS

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

文章

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務